US Stock MarketDetailed Quotes

VRDN Viridian Therapeutics

Watchlist
  • 15.490
  • +0.570+3.82%
Close Aug 16 16:00 ET
  • 15.490
  • 0.0000.00%
Post 18:13 ET
989.65MMarket Cap-3644P/E (TTM)

Viridian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viridian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 53.230K--
--2024/Q3-- / 51.310K--
--2024/Q272.000K / 91.690K--
May 8, 20242024/Q172.000K / 79.830K--
--2023/Q472.000K / 154.180K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 53.230K--
--2024/Q3-- / 51.310K--
--2024/Q272.000K / 91.690K--
May 8, 20242024/Q172.000K / 79.830K--
--2023/Q472.000K / 154.180K--

Unlock Free Earnings Estimates

Viridian Therapeutics Earnings Reports

  • Viridian Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 08:04 ET

  • Viridian Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 07:53 ET

  • Viridian Therapeutics | 10-K: FY2023 Annual Report

    Feb 27 16:42 ET

  • Viridian Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 13, 2023 16:28 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 13, 2024

    Strong Buy

    • Buy

      92.86%

    • Hold

      7.14%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg